Cargando…
Glibenclamide Alleviates LPS-Induced Acute Lung Injury through NLRP3 Inflammasome Signaling Pathway
Glibenclamide displays an anti-inflammatory response in various pulmonary diseases, but its exact role in lipopolysaccharide- (LPS-) induced acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) remains unknown. Herein, we aimed to explore the effect of glibenclamide in vivo and in v...
Autores principales: | Yang, Jie, Yang, Jiawen, Huang, Xiaofang, Xiu, Huiqing, Bai, Songjie, Li, Jiahui, Cai, Zhijian, Chen, Zhanghui, Zhang, Shufang, Zhang, Gensheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856806/ https://www.ncbi.nlm.nih.gov/pubmed/35185385 http://dx.doi.org/10.1155/2022/8457010 |
Ejemplares similares
-
A Protective Role of Glibenclamide in Inflammation-Associated Injury
por: Zhang, Gensheng, et al.
Publicado: (2017) -
Glibenclamide alleviates inflammation in oleic acid model of acute lung injury through NLRP3 inflammasome signaling pathway
por: Chen, Hong, et al.
Publicado: (2019) -
Fludarabine inhibits type I interferon-induced expression of the SARS-CoV-2 receptor angiotensin-converting enzyme 2
por: Xiu, Huiqing, et al.
Publicado: (2021) -
The Role of Macrophages in the Pathogenesis of ALI/ARDS
por: Huang, Xiaofang, et al.
Publicado: (2018) -
A 4-Benzene-Indol Derivative Alleviates LPS-Induced Acute Lung Injury Through Inhibiting the NLRP3 Inflammasome
por: Li, Junmei, et al.
Publicado: (2022)